BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30711979)

  • 1. Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.
    Watanabe A; Harimoto N; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Yoshizumi T; Shirabe K
    Anticancer Res; 2019 Feb; 39(2):941-947. PubMed ID: 30711979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
    Chen Q; Yang LX; Li XD; Yin D; Shi SM; Chen EB; Yu L; Zhou ZJ; Zhou SL; Shi YH; Fan J; Zhou J; Dai Z
    Tumour Biol; 2015 Jul; 36(7):5283-9. PubMed ID: 25672606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Impact of Leucine-Rich α-2-Glycoprotein-1 in Cholangiocarcinoma and Its Association With the IL-6/TGF-β1 Axis.
    Jin Z; Kobayashi S; Gotoh K; Takahashi T; Eguchi H; Naka T; Mori M; Doki Y
    J Surg Res; 2020 Aug; 252():147-155. PubMed ID: 32278969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    Chiu TJ; Chen YJ; Kuo FY; Chen YY
    PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.
    Bunsiripaiboon P; Sornmayura P; Wilasrusmee C; Lertsithichai P
    J Med Assoc Thai; 2010 Jan; 93(1):66-72. PubMed ID: 20196413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.
    Tokuda K; Morine Y; Saito Y; Yamada S; Miyazaki K; Yamashita S; Okikawa S; Ikemoto T; Imura S; Shimada M
    Int J Clin Oncol; 2020 Dec; 25(12):2083-2089. PubMed ID: 32869120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
    Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.
    Gil E; Joh JW; Park HC; Yu JI; Jung SH; Kim JM
    World J Surg Oncol; 2015 Jul; 13():227. PubMed ID: 26216347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.
    Shirabe K; Shimada M; Tsujita E; Aishima S; Maehara S; Tanaka S; Takenaka K; Maehara Y
    Am J Surg; 2004 Apr; 187(4):538-42. PubMed ID: 15041507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.
    Ohira M; Kobayashi T; Hashimoto M; Tazawa H; Abe T; Oshita A; Kohashi T; Irei T; Oishi K; Ohdan H;
    Int J Surg; 2018 Jun; 54(Pt A):156-162. PubMed ID: 29730072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of neutrophil/prealbumin ratio for intrahepatic cholangiocarcinoma undergoing curative resection.
    Huang XT; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    HPB (Oxford); 2018 Dec; 20(12):1215-1222. PubMed ID: 30078755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
    Ohta S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Wada Y; Yamashita S; Bando Y; Shimada M
    Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
    Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
    Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
    BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
    Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.